Evolocumab in Patients With Acute MI
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT04082442
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT04082442
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04082442. Randomized; quadruple masking; primary purpose treatment. Start 2019-09-01 (actual); primary completion 2024-10-25 (actual). Results posted on 2025-10-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evolocumab in Patients With Acute MI
- Acronym
- EVACS II
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Evolocumab
- Intervention (Drug)
- Placebos
- Lead sponsor
- Johns Hopkins University
- Collaborator
- Amgen
Record details
- Record id
cardio:ct-nct04082442- Content hash
777ccf6bbb7fa1c57d0d5f38c98c4c6d115545093b551accab091debfa4b31f3